You have 9 free searches left this month | for more free features.

NPDR

Showing 26 - 50 of 90

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetic Retinopathy Trial in Guadalajara (Combined antioxidant therapy, Placebo)

Completed
  • Diabetic Retinopathy
  • Combined antioxidant therapy
  • Placebo
  • Guadalajara, Jalisco, Mexico
    Institute of Experimental and Clinical Therapeutics,
Mar 21, 2022

Specular Microscopy in Proliferative Diabetic Retinopathy

Not yet recruiting
  • Corneal Endothelial Cell Changes in Diabetic Patients
  • Specular microscopy
  • (no location specified)
Apr 28, 2023

WF and PR OCTA in Diabetic Retinopathy

Recruiting
  • Diabetic Retinopathy
    • Portland, Oregon
      Oregon Health & Science University
    Sep 21, 2021

    Liver X Receptor asNovel Therapeutic Target in Diabetic

    Recruiting
    • Diabetic Retinopathy
    • blood draw
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 13, 2021

    Diabetic Retinopathy Trial in Créteil (Nutrof, Meralut)

    Recruiting
    • Diabetic Retinopathy
    • Nutrof
    • Meralut
    • Créteil, Creteil, France
      CHI Creteil
    Dec 14, 2022

    OCT Biomarkers for Diabetic Retinopathy

    Active, not recruiting
    • Diabetic Retinopathy
      • Portland, Oregon
        Oregon Health & Science University
      Jul 13, 2021

      Diabetic Retinopathy Trial in Beijing (RC28-E injection)

      Recruiting
      • Diabetic Retinopathy
      • RC28-E injection
      • Beijing, Beijing, China
        Beijing Hospital
      Jun 10, 2021

      Nonproliferative Diabetic Retinopathy Trial in Worldwide (Intravitreal aflibercept injection [IAI], Sham)

      Completed
      • Nonproliferative Diabetic Retinopathy
      • Intravitreal aflibercept injection [IAI]
      • Sham
      • Phoenix, Arizona
      • +88 more
      Jul 15, 2020

      Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Riyadh (Bevacizumab)

      Completed
      • Non-proliferative Diabetic Retinopathy
      • +2 more
      • Riyadh, Saudi Arabia
        King Khaled Eye Specialist Hospital
      Dec 2, 2021

      Diabetic Retinopathy Trial in United States (AKST4290, Placebo)

      Suspended
      • Diabetic Retinopathy
      • Phoenix, Arizona
      • +16 more
      Mar 4, 2022

      Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)

      Recruiting
      • Diabetic Retinopathy
      • Runcaciguat (BAY1101042)
      • Placebo
      • Redlands, California
      • +85 more
      Jan 30, 2023

      Diabetic Macular Edema Trial in France (Dexamethasone with 2 loading doses followed by PRN regimen.)

      Recruiting
      • Diabetic Macular Edema
      • Dexamethasone with 2 loading doses followed by PRN regimen.
      • Avignon, France
      • +19 more
      Feb 25, 2022

      Diabetic Retinopathy Trial in Worldwide (Placebo, RG7774)

      Active, not recruiting
      • Diabetic Retinopathy
      • Phoenix, Arizona
      • +67 more
      Aug 19, 2022

      Diabetic Macular Edema - Obstructive Sleep Apnea Relationship

      Active, not recruiting
      • Diabetic Macular Edema
      • +2 more
      • Aflibercept 40 MG/ML [Eylea]
      • +2 more
      • Brampton, Otario, Canada
        Uptown Eye Speicialists
      Nov 23, 2020

      Nonproliferative Diabetic Retinopathy Trial (Lucentis)

      Completed
      • Nonproliferative Diabetic Retinopathy
      • (no location specified)
      May 8, 2020

      Diabetic Retinopathy Trial in Houston, The Woodlands (Aflibercept Injection)

      Completed
      • Diabetic Retinopathy
      • Aflibercept Injection
      • Houston, Texas
      • +1 more
      May 19, 2021

      Diabetic Retinopathy, Artificial Intelligence, Screening Trial in Bangkok (Artificial Intelligence)

      Not yet recruiting
      • Diabetic Retinopathy
      • +2 more
      • Artificial Intelligence
      • Bangkok, Thailand
        Rajavithi hospital
      Dec 22, 2021

      Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

      Recruiting
      • Mild Non-proliferative Diabetic Retinopathy
      • +2 more
      • Ranibizumab Injection [Lucentis]
      • Phacoemulsification
      • Shanghai, Shanghai, China
        Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
      May 18, 2022

      Nonproliferative Diabetic Retinopathy Trial in United States (AKB-9778, Placebo)

      Completed
      • Nonproliferative Diabetic Retinopathy
      • Phoenix, Arizona
      • +52 more
      Jul 24, 2019

      Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy Trial in Torrance

      Completed
      • Diabetic Macular Edema
      • +2 more
      • dexamethasone intravitreal implant
      • intravitreal bevacizumab
      • Torrance, California
        Retina Macula Institute
      Mar 8, 2021

      Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

      Completed
      • Diabetic Macular Edema
      • Phoenix, Arizona
      • +194 more
      Apr 1, 2022

      Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

      Completed
      • Diabetic Macular Edema
      • Mesa, Arizona
      • +184 more
      Apr 1, 2022

      Diabetes, Diabetic Nephropathies Trial in Singapore (Fenofibrate)

      Recruiting
      • Diabetes Mellitus
      • Diabetic Nephropathies
      • Singapore, Singapore
        Singapore General Hospital
      Dec 10, 2020

      Diabetic Retinopathy, Dyslipidemias, Diabetes Trial (Fenofibrate, Placebo)

      Completed
      • Diabetic Retinopathy
      • +2 more
      • (no location specified)
      May 9, 2021

      Severe Non-proliferative Diabetic Retinopathy Trial in Manchester (Green Pascal, Yellow Pascal)

      Withdrawn
      • Severe Non-proliferative Diabetic Retinopathy
      • Green Pascal
      • Yellow Pascal
      • Manchester, England, United Kingdom
        Central Manchester Foundation Trust
      Mar 16, 2020